Skip to main content
. 2020 Jan 21;11(3):237–249. doi: 10.18632/oncotarget.27428

Figure 3.

Figure 3

Association of (AC) VHL mutation and (DF) VHL deletions (3p) in clear cell carcinoma and overall survival (A, D), relapse-free survival (B, E), and cancer specific death (C, F).